Spragens Jeffrey G

Spragens Jeffrey G is listed in filings as Director at SAB Biotherapeutics, Inc.. This profile follows SEC Form 4 activity through Jul 17, 2024, including 1 public disclosure. Recent filings connect the profile to SAB Biotherapeutics, Inc. (SABS). The current snapshot covers public activity from Jul 17, 2024. Reported amounts are shown as $58.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.